Clinical Trials on Neurogenic Bladder in Hong Kong
Total 50 results
-
Chinese University of Hong KongRecruitingBladder Cancer | Bladder Tumor | Bladder NeoplasmHong Kong
-
Chinese University of Hong KongThe University of Hong Kong; Queen Elizabeth Hospital, Hong Kong; North District... and other collaboratorsCompleted
-
Chinese University of Hong KongRecruiting
-
Yung NAQueen Mary Hospital, Hong Kong; Pamela Youde Nethersole Eastern HospitalRecruitingMuscle-Invasive Bladder Carcinoma | Muscle Invasive Bladder Urothelial CarcinomaHong Kong
-
The Hong Kong Polytechnic UniversityNot yet recruitingOveractive Bladder | Urgency Urinary IncontinenceHong Kong
-
Chinese University of Hong KongCompletedHyperthermia | Bladder Cancer | Chemotherapy EffectHong Kong
-
The University of Hong KongHospital Authority, Hong KongRecruiting
-
The University of Hong KongQueen Mary Hospital, Hong KongRecruiting
-
The University of Hong KongCompleted
-
Chinese University of Hong KongUnknownUrinary Bladder TumorHong Kong
-
PfizerCompletedOveractive Bladder | Neurogenic Detrusor OveractivityUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
KYU-SUNG LEEPfizerCompletedOveractive BladderKorea, Republic of
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); VA Long Beach Healthcare System; Nonagen Bioscience...Recruiting
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveChina
-
Zhujiang HospitalGuangdong Xiangxue Precision Medical Technology Co., Ltd.; Xiangxue Life Science... and other collaboratorsCompletedSolid Tumor | Breast Cancer Stage IV | Gastric Cancer Stage IV | Ovarian Cancer Stage IV | Liver Cancer Stage IV | Esophageal Cancer, Stage IV | Bone and Soft Tissue Tumors | Bladder Carcinoma Stage IV | Prostate Carcinoma Stage IV | Thyroid Cancer Stage IVChina
-
GlaxoSmithKlineTerminatedOveractive Bladder | Incontinence, Urinary and Urinary Bladder, OveractiveUnited States
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, Los Angeles; University... and other collaboratorsRecruitingBladder CancerUnited States, Japan
-
CG Oncology, Inc.Merck Sharp & Dohme LLCActive, not recruitingNon Muscle Invasive Bladder CancerUnited States, Korea, Republic of
-
Imbrium TherapeuticsPurdue Pharma LPActive, not recruiting
-
PfizerCompletedOveractive BladderKorea, Republic of, Taiwan, Hong Kong, Japan
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Czech Republic, Poland, Hungary, Belgium, Germany
-
Theravance BiopharmaCompletedParkinson Disease | Orthostatic Hypotension | Neurogenic Orthostatic Hypotension | Hypotension, Orthostatic | Pure Autonomic Failure | Multiple System Atrophy (MSA) With Orthostatic Hypotension | Pure Autonomic Failure With Orthostatic Hypotension | Parkinson Disease With Orthostatic HypotensionUnited States
-
Theravance BiopharmaCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States, Spain, Israel, Hungary, Portugal, Australia, Canada, Germany, Russian Federation, Estonia, France, Italy, United Kingdom, Denmark, Poland, New Zealand, Austria, Bulgaria, Ukraine
-
PfizerCompletedOveractive BladderDenmark, United States, Canada, Costa Rica, Belgium, Czech Republic, Colombia, Germany, Hungary, Korea, Republic of, Spain, Chile, Taiwan, India, Brazil, Singapore, Greece, Hong Kong, Italy, Sweden, Poland, South Africa, Malaysia, Rom... and more
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
-
Hoffmann-La RocheRecruitingMuscle-invasive Bladder CancerBelgium, Korea, Republic of, Japan, Brazil, China, United States, Singapore, France, United Kingdom, Canada, Greece, Italy, Spain, Turkey, Russian Federation, Ukraine, Israel, Czechia, Colombia, Hong Kong, Argentina, Germany, Ireland, Polan... and more
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada
-
AstraZenecaRecruitingMuscle Invasive Bladder CancerNetherlands, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Poland, Spain, Turkey, Vietnam, Argentina, Japan, France, Brazil, Taiwan, United States, Israel, Austria, Chile, Colombia, Greece, Hong Kong, Mexico, Portugal, Russian... and more
-
Bristol-Myers SquibbTerminatedUrinary Bladder NeoplasmsUnited States, Argentina, Australia, Brazil, Canada, Chile, China, France, Mexico, Netherlands, Spain, United Kingdom, Italy, Hong Kong, Russian Federation
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Recruiting
-
NovartisProcter and GambleCompletedUrinary IncontinenceUnited States
-
PfizerTerminatedCystitis, InterstitialCanada, United States, Spain, Belgium, Slovakia, Korea, Republic of, Finland, Hong Kong, Japan, Poland, Romania, Russian Federation, Sweden, Taiwan
-
Urovant Sciences GmbHCompleted
-
Targacept Inc.CompletedOveractive BladderUnited States
-
National Cancer Institute (NCI)RecruitingStage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 | Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
PfizerCompletedOveractive BladderUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedUrinary IncontinenceUnited States
-
MediciNovaCompletedInterstitial CystitisUnited States
-
Urovant Sciences GmbHCompletedOveractive BladderUnited States, Latvia, Hungary, Canada, Lithuania, Poland
-
Urovant Sciences GmbHActive, not recruitingOveractive BladderUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
IpsenTerminatedOveractive Bladder | Urinary IncontinenceUnited States, Korea, Republic of, Czechia, Netherlands, Romania, Poland, Turkey, Portugal, Canada, Italy
-
xCuresCancer CommonsAvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesMelanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Melanoma | Sarcoma | Acute Myeloid Leukemia | Stage I Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Stage III Pancreatic... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingGlioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditionsUnited States, Puerto Rico, Guam